HealthCap

HealthCap is a prominent Stockholm-based venture capital firm with a specialized focus on multi-stage life sciences companies, including biotechnology, medical technology, diagnostics, and digital health. Established in 1996, the firm has cultivated a strong reputation for identifying and nurturing innovative companies from their early stages through to commercial success. With a deep understanding of the scientific and commercial complexities within the life sciences sector, HealthCap leverages its extensive network and expertise to support its portfolio.

Over its more than two decades of operation, HealthCap has demonstrated significant fundraising prowess, having successfully raised over EUR 1 billion across nine dedicated funds. Their latest fund, HealthCap IX, closed in 2021 with commitments totaling €200 million, underscoring their continued ability to attract substantial capital for life sciences investments. The firm's investment strategy is characterized by its willingness to lead funding rounds, providing substantial capital and strategic guidance to its portfolio companies, primarily across Europe and occasionally in the United States.

HealthCap's investment track record is robust, with the firm having invested in more than 100 companies since its inception. This extensive portfolio includes numerous successful exits through initial public offerings (IPOs) and strategic acquisitions, highlighting their proficiency in generating returns for their limited partners. Notable successes include companies that have gone on to become leaders in their respective fields, contributing significantly to advancements in healthcare.